Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
14 Research Pl
North Chelmsford, MA 01863Phone+1 978-256-6607Fax+1 978-250-8189
Education & Training
- Lahey ClinicFellowship, Clinical Cardiac Electrophysiology, 2006 - 2007
- Lahey ClinicFellowship, Cardiovascular Disease, 2003 - 2006
- Lahey ClinicResidency, Internal Medicine, 1998 - 2002
- Albany Medical CollegeClass of 1998
Certifications & Licensure
- MA State Medical License 2002 - 2025
- NH State Medical License 2024 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 3 citationsAuthor Correction: The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans.Benjamin A. H. Smith, Carolyn R. Bertozzi
Nature Reviews. Drug Discovery. 2021-02-08 - 71 citationsGenome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7Simon Wisnovsky, Leonhard Möckl, Stacy A. Malaker, Kayvon Pedram, Gaelen T. Hess
Proceedings of the National Academy of Sciences of the United States of America. 2021-02-02 - 219 citationsThe clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycansBenjamin A. H. Smith, Carolyn R. Bertozzi
Nature Reviews. Drug Discovery. 2021-01-18
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: